FDA clears Leqembi Iqlik subcutaneous shot as Alzheimer's start dose

July 13, 2026 10:38 PM

The U.S. Food and Drug Administration has approved a supplemental Biologics License Application for Leqembi Iqlik® (lecanemab-irmb) as a once-weekly ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found